BY ANJA HAUGE
-
Copy manufacturers criticize EU plan to shorten drug protection period
If the Council of Ministers has its method, fake medications will certainly be given market quicker in the future. However that’s not always a good idea, according to busines…
-
EU’s market protection plans met with criticism: “We’re digging the hole deeper”
3 single-interest group have couple of words of appreciation for the proposition to reduce the marketplace security duration for medications offered by EU priests on Wednesday.
-
Novo Nordisk CEO sees new EU plan creating “uncertainty” and jeopardizing life science investments
The proposition from the EU Council of Ministers on Wednesday “is a lost possibility to position European life scientific research at the facility of international competitor…
-
Novo Holdings sold “stealth company” to French genetic medicine developer
According to a news, the take care of a stealth setting firm seems component of a bigger financial investment in French Coave Rehabs.
-
EU aims to simplify rules and ensure more capital for biotech companies: “It will be a benefit”
EU Parliament wishes to make life less complicated for the biotech sector. The European sector company and the Danish firm Tetra Pharm Technologies delight in.
-
Media: Novo Nordisk employees refer to CEO firing as their “Trump moment”
” The unpredictability is big,” states a Novo Nordisk staff member.
-
EU aims to simplify rules and ensure more capital for biotech companies: “It will be a benefit”
EU Parliament wants to make life easier for the biotech industry. The European industry organization and the Danish company Tetra Pharm Technologies are pleased.
-
Sanofi acquires US-based Vigil Neuroscience
The procurement enhances the French pharmaceutical firm’s initiatives in the therapy of Alzheimer’s.
-
Analysts speculate to media: Layoffs may be on the way at Novo Nordisk
According to Børsen, experts and consultants hypothesize that rival Eli Lilly’s greater income regardless of dramatically less workers is a primary factor for Novo Nordisk…
-
Novo Nordisk Foundation initiated Fruergaard’s exit: “The timing is right”
At the exact same time, the structure will certainly currently boost its existence on Novo Nordisk’s board of supervisors.
